Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

On January 22, AstraZeneca (AZ) announced the approval of Xigduo (dapagliflozin and metformin hydrochloride) for the treatment of type 2 diabetes in Europe. The drug is...
All about diabetic macular edema (DME) and three tips for avoiding it.
Sanofi US has worked with the award-winning actor Elizabeth Perkins to film and produce Strength in Numbers , a compelling 15-minute documentary about people with...
At a recent meeting of Oregon’s Health Evidence Review Commission (HERC), the state panel recommended reducing access to test strips for people with type 2 diabetes on...
How do you stay healthy and happy with diabetes? Kerri shares five lessons she has learned over the years.
Cellnovo recently launched its mobile-enabled insulin pump system in the UK, after receiving very positive feedback from a usability study that began in the UK in...
A game-changing therapy for type 2 diabetes? Plus, the latest on predictive low glucose suspend, faster insulin, and a better Bydureon.
On June 13, WellDoc announced the upcoming launch of BlueStar , an FDA-approved software-based product that is prescribed by a HCP to support the management of type 2...
On July 31, the ADA issued a statement on the importance of accurate blood glucose meters and test strips, calling for the FDA to continually monitor product quality and...
On December 11, Orexigen announced the resubmission of its weight management drug Contrave (naltrexone/bupropion) to the FDA. The company has previously stated that it...
What apps are best for diabetes? What we learned at this year’s AADE 2013.
At the end of March, encouraging news about Takeda’s once-daily pill for type 2 diabetes, Nesina (alogliptin), circulated at the American College of Cardiology (ACC)...
On October 12, the Taking Control of Your Diabetes (TCOYD) conference and health fair will be held in Omaha, NE at the Omaha Convention Center. The one-day conference...
On January 10, WellDoc, a clinical and behavioral science company founded by Joslin endocrinologists, announced that it received $20 million of funding, including...
Five things people with diabetes need to know about the Affordable Care Act.
The consensus from most speakers at the workshop was that, while this possible link does require further investigation, the available evidence does not suggest any need...
On October 23, the ADA announced the creation of its “ Make the Link” Diabetes and Coronary Artery Disease Resource Toolkit . Although the toolkit is originally intended...
Downloading data, CGMs and insurance coverage, and how the Mediterranean diet is good for your heart.
‘Needlephobia’ and the hassle of multiple daily injections can be a significant barrier to taking insulin. Encouragingly, Medtronic recently made its i-port Advance...
MannKind’s inhalable ultra-rapid-acting insulin Afrezza has its day at the FDA – find out what it can do for patients and how to speak up!

Pages